Stay updated on Pembrolizumab + Fulvestrant in HR+ HER2- Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Fulvestrant in HR+ HER2- Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Fulvestrant in HR+ HER2- Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T12:33:58.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, while removing the previous wording about those conducting the study.
    Difference
    2%
    Check dated 2024-12-07T10:46:30.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Several key medical and genetic resource links have been removed, including those related to breast cancer and hormone information, which may impact access to important health information.
    Difference
    4%
    Check dated 2024-11-23T04:25:47.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The website has added several new resources related to genetics and breast cancer, including links to MedlinePlus and DailyMed, as well as new data fields for study information, while updating the revision from v2.12.1 to v2.12.2.
    Difference
    4%
    Check dated 2024-11-15T23:15:38.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The website has been updated from version v2.12.0 to v2.12.1.
    Difference
    0.1%
    Check dated 2024-11-01T11:51:37.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.
    Difference
    0.1%
    Check dated 2024-10-25T01:34:35.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Fulvestrant in HR+ HER2- Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Fulvestrant in HR+ HER2- Breast Cancer Clinical Trial page.